3-Spirocyclic indolyl derivatives useful as ORL-1 receptor modulators
摘要
The present invention is directed to novel 3-spirocyclic indolyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the ORL-1 receptor.